Company mis-guidance and funny buggers., page-24

Ok, I've been trying to get myself through the "confusion" and came up with the following:

from the B-Vaxx publication link, anns, 26 Feb.

Patient 2C received seven 6 months booster vaccinations. Patient 2C travelled to Columbus, Ohio from Seattle, Washington to receive his first vaccine on 05/30/2012 and two boosters at 3 weeks apart. The patient returned every 6 months through 12/10/2015 to receive the 7 booster vaccinations, spanning 3.5 years. Prior to enrollment in our study, this patient was diagnosed with T2N2bM0 poorly differentiated carcinoma of the right parotid gland and underwent radical parotidectomy and selective right neck dissection. The surgical pathology revealed 25 lymph nodes positive for metastatic disease. Interestingly, the tumor also had "patchy foci" of 3+ Her2/neu staining based on immunohistochemistry on a background of equivocal 2+ positivity. Recurrence was discovered in the right axillary lymph nodes about 2 years later and the patient underwent right axillary lymph node dissection which revealed that four of 46 lymph nodes were positive. He was subsequently enrolled in our study. The exceptional response in this patient may also be due to the fact that this patient did not receive any chemotherapy prior to enrollment. Thus, his immune system was very much intact and likely more responsive to vaccine treatment. This is an important fact as the vaccine therapy should be more effective in such patients.

Plus, PFS of 41 months according to page 13, IMU-Website Wholesale-Presentation Feb-March, of patient 2C.

That indicated to me a Complete Response but I guess it is not.


2. I compared the Investor-Preso from 10-01-2019 with the current Wholesale-Preso and discovered like many here the differences / changes / additions.

When I wrote my previous posts I had the January's Investor-Preso in mind a I just got that stored on my phone.

I agree it is strange they did not highlight the amendments / additions in an extra anns, especially the 1 CR page 9 which we were not informed about. Let's hope it is not just a typo.

But in the end the most important fact is the 2 vaxx represent the new and more effective way in cancer treatment and that's what counts.

SP and MC haven't changed much but it won't take long I guess. Just a few Bio-tech US investors / pharma need to read that and it could explode the next morning.

And yes, IMU has to improve the way they communicate to / with us. 

GLTA